ATRA icon

Atara Biotherapeutics
ATRA

Overview Fund Activity

109 hedge funds and large institutions have $131M invested in Atara Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 20 closing their positions.

Holders
109
Holders Change
-9
Holders Change %
-7.63%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
42
Reduced
38
Closed
20
Calls
$1.82M
Puts
$98K
Net Calls
+$1.72M
Net Calls Change
-$471K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$12.8M
2
AQR Capital Management
2
AQR Capital Management
Connecticut
$1.25M
3
DCM
3
Driehaus Capital Management
Illinois
$873K
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$839K
5
Citadel Advisors
5
Citadel Advisors
Florida
$2.47M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.23M
2
Millennium Management
2
Millennium Management
New York
$484K
3
BlackRock
3
BlackRock
New York
$11.4M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$5.79M
5
Goldman Sachs
5
Goldman Sachs
New York
$6.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
Stifel Financial
126
Stifel Financial
Missouri
– -$20.1K -499 Closed
QT
127
Quantbot Technologies
New York
– -$6.28K -156 Closed
CG
128
Cutler Group
California
– -$2K -60 Closed
2 3 4 5
6